Your browser doesn't support javascript.
loading
The prognostic significance of lymphovascular invasion in cutaneous squamous cell carcinoma.
Huang, Sarah Suruo; Toon, Christopher W; Harish, Varun.
Afiliación
  • Huang SS; Department of Burns, Plastic & Maxillofacial Surgery, Royal North Shore Hospital, Sydney, Australia.
  • Toon CW; Northern Clinical School, University of Sydney, Sydney, Australia.
  • Harish V; Department of Anatomical Pathology, Royal North Shore Hospital, Sydney, Australia.
ANZ J Surg ; 93(11): 2727-2735, 2023 11.
Article en En | MEDLINE | ID: mdl-37727039
BACKGROUND: The majority of cutaneous squamous cell carcinomas (cSCC) have a favourable prognosis. However, a subset of cases follow an aggressive disease course with progression to metastasis and death. Several histopathological parameters are associated with poor outcomes, but lymphovascular invasion (LVI) has not been well studied. OBJECTIVE: To assess the prognostic significance of LVI in cSCC and determine associations between LVI and cSCC. METHODS: A retrospective review of 486 consecutive cases of cSCC over a 5-year period from a single centre was stratified by the presence or absence of LVI. Logistic regression and multivariate survival analysis were used to determine associations of LVI and prognostic significance of LVI, respectively. FINDINGS: LVI was present in 41 cases (9.2%). LVI was significantly associated with increasing depth of invasion, microanatomical tumour location (subcutis vs. dermis), and tumour dimensions (P < 0.05). Univariate survival analysis revealed significantly lower 2-year overall survival rates for patients with LVI (37.1%) compared with those without (66.6%) (95% CI = 60.6-73.3, P < 0.001). LVI was also found to be an independent marker of poor disease-specific survival (HR = 0.232 (95% CI = 0.090-0.600), P = 0.003), poor overall survival (HR 0.338 (95% CI = 0.184-0.623), P < 0.001) and poor disease-free survival (HR 0.461 (95% CI = 0.230-0.923), P = 0.029) through multivariate analysis. CONCLUSIONS: This study confirms that LVI is an independent poor prognosticator in cSCC, with significantly worse survival indices at 2 years. Future systems of risk stratification for cSCC should incorporate LVI.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Carcinoma de Células Escamosas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: ANZ J Surg Año: 2023 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Carcinoma de Células Escamosas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: ANZ J Surg Año: 2023 Tipo del documento: Article País de afiliación: Australia